Showing results (1341-1350 of 1,478) with videos related to

Sort By:
Pageof 148
Circulation Research|February 3, 2022
Mitochondrial Creatine Kinase Attenuates Pathologic Remodeling in Heart FailureGizem Keceli, Ashish Gupta, Joevin Sourdon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2024
Impact of Intrapartum Azithromycin on the Carriage and Antibiotic Resistance of Escherichia coli and Klebsiella pneumoniae in Mothers and Their Newborns: A Substudy of a Randomized, Double-Blind Trial Conducted in The Gambia and Burkina FasoPauline Getanda, Isatou Jagne, Joel D Bognini, et al.
PLOS Global Public Health|October 18, 2023
Effect and cost-effectiveness of human-centred design-based approaches to increase adolescent uptake of modern contraceptives in Nigeria, Ethiopia and Tanzania: Population-based, quasi-experimental studiesCatarina Krug, Melissa Neuman, James E Rosen, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 2, 2010
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trialsJohn T Maringwa, Chantal Quinten, Madeleine King, et al.
The Biochemical Journal|July 31, 2013
Mining the bacterial unknown proteome: identification and characterization of a novel family of highly conserved protective antigens in Staphylococcus aureusChristina Schluepen, Enrico Malito, Ambra Marongiu, et al.
BJU International|November 30, 2023
Health-related quality of life after a diagnosis of bladder cancer: a longitudinal survey over the first yearZoe Rogers, Adam Glaser, James W F Catto, et al.
Frontiers in Bioinformatics|August 5, 2025
Design of cross-reactive antigens with machine learning and high-throughput experimental evaluationChelsy Chesterman, Thomas Desautels, Luz-Jeannette Sierra, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 18, 2002
(E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-phenyl-3-butenyl]-2'-isobutyl-2'-(methanesulfonyl)-4-methylvalerohydrazide (Ro 32-7315), a selective and orally active inhibitor of tumor necrosis factor-alpha convertaseG Beck, G Bottomley, D Bradshaw, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
An international study to revise the EORTC questionnaire for assessing quality of life in lung cancer patientsM Koller, M J Hjermstad, K A Tomaszewski, et al.
Cancer|October 16, 2013
A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sitesChantal Quinten, Francesca Martinelli, Corneel Coens, et al.
Pageof 148